1. Home
  2. ARQT vs AVAH Comparison

ARQT vs AVAH Comparison

Compare ARQT & AVAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARQT
  • AVAH
  • Stock Information
  • Founded
  • ARQT 2016
  • AVAH 1984
  • Country
  • ARQT United States
  • AVAH United States
  • Employees
  • ARQT N/A
  • AVAH N/A
  • Industry
  • ARQT Biotechnology: Pharmaceutical Preparations
  • AVAH Hospital/Nursing Management
  • Sector
  • ARQT Health Care
  • AVAH Health Care
  • Exchange
  • ARQT Nasdaq
  • AVAH Nasdaq
  • Market Cap
  • ARQT 1.1B
  • AVAH 1.1B
  • IPO Year
  • ARQT 2020
  • AVAH 2021
  • Fundamental
  • Price
  • ARQT $12.68
  • AVAH $4.65
  • Analyst Decision
  • ARQT Strong Buy
  • AVAH Hold
  • Analyst Count
  • ARQT 5
  • AVAH 4
  • Target Price
  • ARQT $17.00
  • AVAH $4.51
  • AVG Volume (30 Days)
  • ARQT 2.0M
  • AVAH 242.5K
  • Earning Date
  • ARQT 02-25-2025
  • AVAH 03-13-2025
  • Dividend Yield
  • ARQT N/A
  • AVAH N/A
  • EPS Growth
  • ARQT N/A
  • AVAH N/A
  • EPS
  • ARQT N/A
  • AVAH N/A
  • Revenue
  • ARQT $138,708,000.00
  • AVAH $1,983,475,000.00
  • Revenue This Year
  • ARQT $209.03
  • AVAH $7.85
  • Revenue Next Year
  • ARQT $49.00
  • AVAH $5.09
  • P/E Ratio
  • ARQT N/A
  • AVAH N/A
  • Revenue Growth
  • ARQT 182.84
  • AVAH 6.21
  • 52 Week Low
  • ARQT $3.11
  • AVAH $2.00
  • 52 Week High
  • ARQT $16.20
  • AVAH $6.19
  • Technical
  • Relative Strength Index (RSI)
  • ARQT 43.06
  • AVAH 46.64
  • Support Level
  • ARQT $13.10
  • AVAH $4.31
  • Resistance Level
  • ARQT $14.36
  • AVAH $4.84
  • Average True Range (ATR)
  • ARQT 0.99
  • AVAH 0.25
  • MACD
  • ARQT -0.32
  • AVAH 0.04
  • Stochastic Oscillator
  • ARQT 1.95
  • AVAH 57.48

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's lead product candidate ZORYVE roflumilast cream, has successfully completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

About AVAH Aveanna Healthcare Holdings Inc.

Aveanna Healthcare Holdings Inc is a diversified home care platform that provides care to medically complex, high-cost patient populations. It directly addresses the pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home. The firm provides its services through three segments: Private Duty Services (PDS); Home Health & Hospice (HHH); and Medical Solutions (MS). Private Duty Services include private duty nursing (PDN) and pediatric therapy services. Revenue is primarily derived from pediatric healthcare services provided to patients including private duty nursing and therapy services, adult home health and hospice services (collectively patient revenue) and from the delivery of enteral nutrition and other products to patients.

Share on Social Networks: